Long-term outcomes following bioresorbable vascular scaffolds

被引：0

作者：

Miyashita, Kotaro ^{[1
,2
]}

Ninomiya, Kai ^{[1
,2
]}

Tobe, Akihiro ^{[1
,2
]}

Masuda, Shinichiro ^{[1
,2
]}

Kotoku, Nozomi ^{[1
,2
]}

Kageyama, Shigetaka ^{[1
,2
]}

Revaiah, Pruthvi C. ^{[1
,2
]}

Tsai, Tsung-Ying ^{[1
,2
]}

Wang, Bo ^{[1
,2
]}

Garg, Scot ^{[3
]}

Serruys, Patrick W. ^{[1
,2
]}

Onuma, Yoshinobu ^{[1
,2
]}

机构：

[1] Univ Galway, Coll Med Nursing & Hlth Sci, Univ Rd, Galway H91 TK33, Ireland

[2] Univ Galway, CORRIB Res Ctr Adv Imaging & Core Lab, Galway, Ireland

[3] Royal Blackburn Hosp, Dept Cardiol, Blackburn, England

来源：

EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2024年 / 22卷 / 08期

关键词：

Drug-eluting stents; bioresorbable scaffold; new generation scaffold; long term outcomes for bioresorbable scaffold; peripheral artery disease; CORONARY-ARTERY-DISEASE; EVEROLIMUS-ELUTING STENTS; OPTICAL COHERENCE TOMOGRAPHY; 2-YEAR CLINICAL-OUTCOMES; METALLIC STENT; 1ST-IN-HUMAN EVALUATION; IMAGING OUTCOMES; ABSORB; IMPLANTATION; LESIONS;

D O I：

10.1080/14779072.2024.2375340

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

IntroductionThe higher scaffold thrombosis rates observed with the first-generation bioresorbable scaffolds (BRSs) compared to conventional drug-eluting stents were likely due in part to bioresorbable polymers having insufficient radial strength, necessitating larger strut profiles. Meta-analysis of the long-term outcomes from the first-generation Absorb bioresorbable vascular scaffold (BVS) showed that this period of excess risk ended at 3 years. Therefore, current attention has been focused on improving early outcomes by increasing the scaffold's tensile strength and reducing strut thickness.Areas coveredThis review summaries the lessons learned from the first-generation BRS. It updates the long-term clinical outcomes of trials evaluating the ABSORB BVS and metallic alloy-based BRS. In addition, it reviews the next-generation BRSs manufactured in Asia.Expert opinionCritical areas to improve the performance and safety of biodegradable scaffolds include further development in material science, surface modification, delivery systems, and long-term follow-up studies.

引用

页码：391 / 407

页数：17

共 112 条

[31] Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease ABSORB China Trial [J].

Gao, Runlin ;

Yang, Yuejin ;

Han, Yaling ;

Huo, Yong ;

Chen, Jiyan ;

Yu, Bo ;

Su, Xi ;

Li, Lang ;

Kuo, Hai-Chien ;

Ying, Shih-Wa ;

Cheong, Wai-Fung ;

Zhang, Yunlong ;

Su, Xiaolu ;

Xu, Bo ;

Popma, Jeffery J. ;

Stone, Gregg W. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (21) :2298-2309

[32] Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial [J].

Gomez-Lara, Josep ;

Ortega-Paz, Luis ;

Brugaletta, Salvatore ;

Cuesta, Javier ;

Romani, Sebastian ;

Serra, Antonio ;

Salinas, Pablo ;

Garcia del Blanco, Bruno ;

Goicolea, Javier ;

Hernandez-Antolin, Rosana ;

Antuna, Paula ;

Romaguera, Rafael ;

Regueiro, Ander ;

Rivero, Fernando ;

Cequier, Angel ;

Alfonso, Fernando ;

Gomez-Hospital, Joan-Antoni ;

Sabate, Manel .

EUROINTERVENTION, 2020, 16 (11) :E913-E921

[33] A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents [J].

Han, Yaling ;

Xu, Bo ;

Fu, Guosheng ;

Wang, Xiaozeng ;

Xu, Kai ;

Jin, Chongying ;

Tao, Ling ;

Li, Lang ;

Hou, Yuqing ;

Su, Xi ;

Fang, Quan ;

Chen, Lianglong ;

Liu, Huiliang ;

Wang, Bin ;

Yuan, Zuyi ;

Gao, Chuanyu ;

Zhou, Shenghua ;

Sun, Zhongwei ;

Zhao, Yanyan ;

Guan, Changdong ;

Stone, Gregg W. .

JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (03) :261-272

[34] A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first- in-human study [J].

Haude, Michael ;

Wlodarczak, Adrian ;

Schaaf, Rene J. van der ;

Torzewski, Jan ;

Ferdinande, Bert ;

Escaned, Javier ;

Iglesias, Juan F. ;

Bennett, Johan ;

Toth, Gabor ;

Joner, Michael ;

Toelg, Ralph ;

Wiemer, Marcus ;

Olivecrona, Goeran ;

Vermeersch, Paul ;

Garcia-Garcia, Hector M. ;

Waksman, Ron .

EUROINTERVENTION, 2023, 19 (05) :E414-U80

[35] Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study [J].

Haude, Michael ;

Wlodarczak, Adrian ;

van der Schaaf, Rene J. ;

Torzewski, Jan ;

Ferdinande, Bert ;

Escaned, Javier ;

Iglesias, Juan F. ;

Bennett, Johan ;

Toth, Gabor ;

Joner, Michael ;

Toelg, Ralph ;

Wiemer, Marcus ;

Olivecrona, Goeran ;

Vermeersch, Paul ;

Garcia-Garcia, Hector M. ;

Waksman, Ron .

ECLINICALMEDICINE, 2023, 59

[36] Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial [J].

Haude, Michael ;

Ince, Hueseyin ;

Toelg, Ralph ;

Lemos, Pedro Alves ;

von Birgelen, Clemens ;

Christiansen, Evald Hoj ;

Wijns, William ;

Neumann, Franz-Josef ;

Eeckhout, Eric ;

Garcia-Garcia, Hector M. ;

Waksman, Ron .

EUROINTERVENTION, 2020, 15 (15) :E1375-+

[37]

Haude M, 2017, EUROINTERVENTION, V13, P432, DOI [10.4244/EIJ-D-17-00254, 10.4244/EIJ.D.17.00254]

[38] Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12 months: Pooled patient level analysis from BIOSOLVE II-III and BIOFLOW II trials [J].

Hideo-Kajita, Alexandre ;

Garcia-Garcia, Hector M. ;

Kolma, Paul ;

Azizi, Viana ;

Ozaki, Yuichi ;

Dan, Kazuhiro ;

Ince, Hueseyin ;

Kische, Stephan ;

Abizaid, Alexandre ;

Toeelg, Ralph ;

Lemos, Pedro Alves ;

Van Mieghem, Nicolas M. ;

Verheye, Stefan ;

von Birgelen, Clemens ;

Christiansen, Evald Hoj ;

Wijns, William ;

Lefevre, Thierry ;

Windecker, Stephan ;

Waksman, Ron ;

Haude, Michael .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 300 :60-65

[39] Fully bioresorbable vascular scaffolds: lessons learned and future directions [J].

Jinnouchi, Hiroyuki ;

Torii, Sho ;

Sakamoto, Atsushi ;

Kolodgie, Frank D. ;

Virmani, Renu ;

Finn, Aloke V. .

NATURE REVIEWS CARDIOLOGY, 2019, 16 (05) :286-304

[40] Adaptive Coronary Artery Rotational Motion Through Uncaging of a Drug-Eluting Bioadaptor Aiming to Reduce Stress on the Coronary Artery [J].

Kansal, Mayank M. ;

Wolska, Beata ;

Verheye, Stefan ;

Vidovich, Mladen I. .

CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 39 :52-57

← 1 2 3 4 5 6 7 8 9 10 →